Niwa Masayuki, Hotta Koichi, Kanamori Yutaka, Hatakeyama Daijiro, Hirade Kouseki, Katayama Masaki, Hara Akira, Mori Hideki, Ito Hidenori, Kato Kanefusa, Matsuno Hiroyuki, Uematsu Toshihiko, Kozawa Osamu
Department of Pharmacology, Gifu University School of Medicine, 40 Tsukasamachi, Gifu 500-8705, Japan.
Eur J Pharmacol. 2003 Apr 18;466(3):245-53. doi: 10.1016/s0014-2999(03)01571-1.
We investigated whether tumor necrosis factor-alpha (TNF-alpha) stimulates the induction of heat shock protein 27 (HSP27) in human neutrophils and the mechanism underlying this induction. In intact neutrophils, almost no HSP27 was detected. Stimulation of neutrophils by TNF-alpha increased the levels of HSP27 in the presence, but not in the absence, of cycloheximide. Reverse transcription-polymerase chain reaction (RT-PCR) experiments showed that TNF-alpha also induced HSP27 mRNA in the presence of cycloheximide. TNF-alpha induced the phosphorylation of p44/p42 mitogen-activated protein (MAP) kinase and p38 MAP kinase. The HSP27 accumulation induced by TNF-alpha was significantly suppressed by 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole (SB203580) or 4-(4-fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole (PD169316); both are specific inhibitors of p38 MAP kinase, but not by 2'-amino-3'-methoxyflavone (PD098059, a specific inhibitor of the upstream kinase that activates p44/p42 MAP kinase). The accumulation of HSP27 induced by TNF-alpha plus cycloheximide was also suppressed by pretreatment with a specific protein kinase C (PKC) inhibitor. Furthermore, phorbol myristate acetate (PMA), a PKC stimulant, but not dibutyryl cyclic AMP, a protein kinase A stimulant, stimulated the accumulation of HSP27. Interestingly, SB203580 did not inhibit PMA-stimulated HSP27 induction. These results strongly suggest that TNF-alpha may act as the regulator of HSP27 induction in neutrophils. p38 MAP kinase (but not p44/p42 MAP kinase) and PKC take part in TNF-alpha-stimulated HSP27 induction in human neutrophils.
我们研究了肿瘤坏死因子-α(TNF-α)是否刺激人中性粒细胞中热休克蛋白27(HSP27)的诱导及其诱导机制。在完整的中性粒细胞中,几乎检测不到HSP27。在存在放线菌酮的情况下,TNF-α刺激中性粒细胞可增加HSP27的水平,但在不存在放线菌酮时则不会。逆转录-聚合酶链反应(RT-PCR)实验表明,TNF-α在存在放线菌酮的情况下也可诱导HSP27 mRNA。TNF-α诱导p44/p42丝裂原活化蛋白(MAP)激酶和p38 MAP激酶的磷酸化。4-(4-氟苯基)-2-(4-甲亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑(SB203580)或4-(4-氟苯基)-2-(4-硝基苯基)-5-(4-吡啶基)-1H-咪唑(PD169316)可显著抑制TNF-α诱导的HSP27积累;这两种都是p38 MAP激酶的特异性抑制剂,但2'-氨基-3'-甲氧基黄酮(PD098059,一种激活p44/p42 MAP激酶的上游激酶的特异性抑制剂)则不能。用特异性蛋白激酶C(PKC)抑制剂预处理也可抑制TNF-α加放线菌酮诱导的HSP27积累。此外,PKC刺激剂佛波醇肉豆蔻酸酯乙酸酯(PMA)可刺激HSP27的积累,但蛋白激酶A刺激剂二丁酰环磷腺苷则不能。有趣的是,SB203580并不抑制PMA刺激的HSP27诱导。这些结果强烈表明,TNF-α可能作为中性粒细胞中HSP27诱导的调节因子。p38 MAP激酶(而非p44/p42 MAP激酶)和PKC参与人中性粒细胞中TNF-α刺激的HSP27诱导。